Implicit Bioscience

This is a small, early-stage study to see if a new drug called atibuclimab (IC14) is safe and might help people who are hospitalized because their heart failure has suddenly gotten worse. The study will enroll 10 adults to receive a single IV infusion of the drug and then be clos…

This early-stage study is testing whether an experimental drug called IC14 can help control arrhythmogenic cardiomyopathy, a serious heart condition that causes dangerous irregular heartbeats. Five patients who already have implanted defibrillators will receive four intravenous i…